The mecholine test is a method of fractional examination of the contents of the duodenum, which is used to assess the exocrine function of the pancreas. This test measures the amount of enzymes released by the pancreas in response to stimulation.
To conduct the mecholin test, the patient is injected into the duodenum with mecholyl, a compound that stimulates the secretion of pancreatic enzymes. After this, duodenal fluid is collected, which is then divided into fractions. Each fraction contains a certain amount of enzymes and other substances that are secreted by the pancreas.
The results of the mecholine test can help in diagnosing diseases of the pancreas and other digestive organs. In addition, this test can be used to evaluate the effectiveness of treatment for pancreatic diseases.
However, like any other research method, the mecholine test has its limitations. For example, it may not be informative in some diseases of the pancreas, and may also be difficult in the presence of gallstones or other obstacles to the passage of mecholyl through the duodenum.
In medicine, the method is used to determine the exocrine capacity of the pancreas and evaluate exocrine therapy in patients with pancreatitis and chronic abdominal pain. According to the mechanism of action, the methyl red test is a fractional determination of phenol content, which can be